Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
atazanavir + ritonavir + tenofovir disoproxil fumarate + emtricitabine
- Development stage
- Phase 4
- Lead developer
- Bristol Myers Squibb
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
This is a combination antiretroviral therapy regimen used for the treatment of HIV-1 infection. It combines four medications: atazanavir (a protease inhibitor), ritonavir (a pharmacokinetic enhancer/booster), and the nucleoside/nucleotide reverse transcriptase inhibitors tenofovir disoproxil fumarate and emtricitabine. Atazanavir is boosted with low-dose ritonavir to optimize its pharmacokinetic parameters and efficacy. This combination has shown potent antiviral activity with once-daily dosing, making it suitable for initial HIV treatment or as part of a treatment regimen for HIV-infected individuals.
- Brand names
- Truvada
- Other names
- ATV/r + FTC/TDFatazanavir/ritonavir + emtricitabine/tenofovir disoproxil fumarate
02
Targets
PR (Progesterone receptor)Human immunodeficiency virus type 1 reverse transcriptase
Beyond the preview
Go deeper on atazanavir + ritonavir + tenofovir disoproxil fumarate + emtricitabine.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on atazanavir + ritonavir + tenofovir disoproxil fumarate + emtricitabine.